Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-09-20
2010-06-29
Anderson, Rebecca L (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S168000
Reexamination Certificate
active
07745438
ABSTRACT:
The present invention provides BACE inhibitors of Formula (I); methods for their use and preparation, and intermediates useful for their preparation.
REFERENCES:
patent: 7388007 (2008-06-01), Thompson et al.
patent: WO 89/03842 (1989-05-01), None
patent: WO03/006021 (2003-01-01), None
patent: WO2004/024081 (2004-03-01), None
patent: WO2004/043916 (2004-05-01), None
patent: WO2005/001450 (2005-02-01), None
patent: WO2005/016876 (2005-02-01), None
patent: WO2005/108358 (2005-11-01), None
patent: WO2005/108391 (2005-11-01), None
Scholz, Dieter et al., Backbone stabilized peptidomimetics containing statine-like structural elements: diastereospecific synthesis of trisubstituted cyclic ureas and 1,4-diazepan-2-ones,Monatshefte Fuer Chemie, 1999, XP002371889, p. 1295, 130(10).
Broughton Howard Barff
Bueno Melendo Ana Belen
Dally Robert Dean
Durham Timothy Barrett
Erickson Jon Andre
Anderson Rebecca L
Coughlin Matthew P
Dingess-Hammond Elizabeth
Eli Lilly and Company
Titus Robert D.
LandOfFree
3-(2-acylamino-1-hydroxyethyl)-morpholine derivatives and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3-(2-acylamino-1-hydroxyethyl)-morpholine derivatives and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-(2-acylamino-1-hydroxyethyl)-morpholine derivatives and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4173604